The Gold Standard: Understanding the HEDS Treatment Strategy

The treatment of HSV stromal keratitis is guided by one of the most important series of clinical trials in ophthalmology: the Herpetic Eye Disease Study (HEDS). These studies established the “gold standard” for how doctors manage this condition today, moving away from guesswork toward a proven strategy of balanced medication ^[1][2].

The “Seesaw” Strategy: Steroids and Antivirals

Treatment for stromal keratitis is a delicate balancing act. Think of it like a seesaw:

1. Topical Corticosteroids (The Inflammation Stopper): Because stromal keratitis is an immune overreaction, steroids are used to “quiet” the immune system. HEDS I proved that adding steroids to your treatment reduces the risk of the disease getting worse or lasting longer by 68% ^[3][4].
2. Antivirals (The Safety Cover): Steroids work by suppressing the immune system, but this also makes it easier for the herpes virus to wake up and start replicating. Therefore, you must never use a steroid without “antiviral cover” ^[5][6]. The antiviral acts as a shield, preventing the virus from causing a surface infection while the steroid heals the deeper layers.

Practical Drop Management

When managing multiple eye drops, a crucial practical tip is to wait 5 to 10 minutes between administering the steroid and the antiviral drops. This spacing prevents the second drop from physically washing the first drop out of your eye before it can be absorbed.

Why You Can’t Stop Steroids Abruptly

One of the most critical findings from the HEDS research is the importance of a slow taper. The study utilized a 10-week tapering schedule for the steroid drops ^[2][7].

If you stop steroid drops too quickly, you may experience rebound inflammation. This happens because the immune cells, which were being held back by the medication, suddenly flood back into the cornea, often causing a flare-up that is worse than the original infection ^[8]. Your doctor will likely reduce your drops slowly (e.g., from four times a day, to three, to two, etc.) over several months to “train” the immune system to stay calm.

Long-Term Protection: HEDS II Findings

While HEDS I focused on treating an active flare-up, HEDS II looked at how to prevent the next one. The study found that taking a low dose of oral antiviral medication (like acyclovir) daily for one year reduced the risk of any type of ocular herpes returning by approximately 50% ^[1].

For patients with a history of stromal keratitis—which carries the highest risk of permanent scarring—this long-term “prophylaxis” (preventative treatment) is often recommended to protect the cornea over the long term ^[9][10].

Summary of the HEDS Protocol

• Dual Therapy: Always combine a steroid (to stop scarring) with an antiviral (to stop the virus) ^[11][12].
• The 10-Week Rule: Steroids should be tapered very slowly to prevent the immune system from rebounding ^[7].
• The 50% Benefit: Long-term oral antivirals significantly cut the risk of future attacks in half ^[1].
• Monitor Pressure: Because steroids can increase eye pressure, your doctor must monitor you closely during the entire treatment period ^[13].

If your eye is not tolerating steroids well, or if the pressure is too high, your doctor may discuss steroid-sparing agents like cyclosporine or tacrolimus, which can help manage the inflammation with fewer side effects ^[14][15].

Return to the Home Page.